Anlotinib in the Treatment of Advanced Hepatocellular Carcinoma (HCC)

NCT03766776 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Cancer of Liver

Interventions

DRUG: Anlotinib

Sponsor

The First Affiliated Hospital with Nanjing Medical University